Optimizing Oral Targeted Therapies for HR+/HER2- Breast Cancer

Content Format:

Podcast

Credit Type:

--

Credits:

--
Targeted Therapy Advances in HR+/HER2- Breast Cancer: Best Practices for Oncology Pharmacists

Content Format:

Text Module

Credit Type:

ACPE-P

Credits:

0.50
Optimizing Oral Targeted Therapies in HR+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

ACPE-P

Credits:

1.00
Optimizing the Use of Targeted Therapies in Breast Cancer: Dosing, Toxicity Management, and Adherence

Content Format:

Text Module

Credit Type:

ACPE-P

Credits:

0.50
Q&A on Oral Targeted Therapies in HR+/HER2- Breast Cancer for Oncology Pharmacists

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Advances in Oral Targeted Therapies for HR+/HER2- Breast Cancer: Best Practices for Oncology Pharmacists

Content Format:

Slideset

Credit Type:

ACPE-P

Credits:

1.00
Patient-Centered Management of CDK4/6 Inhibitor Therapy: Adverse Event Mitigation, Adherence, and Persistence in HR+/HER2- Breast Cancer

Content Format:

Podcast

Credit Type:

ACPE-P

Credits:

1.00
Role of the Multidisciplinary Team in Achieving Comprehensive and Individualized Care of Patients with HR-positive/HER2-negative Metastatic Breast Cancer and Preexisting Comorbidities

Content Format:

Podcast

Credit Type:

--

Credits:

--
Applying Evidence-Based Strategies to Improve Outcomes in HER2-Negative Early Breast Cancer

Content Format:

Video

Credit Type:

ACPE-P

Credits:

1.00
Key Takeaways in the Management of HER2-Negative Early Breast Cancer: Focus on Treating Patients With Pathogenic Variants in Germline BRCA

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Takeaways in the Management of HER2-Negative Early Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Applying Evidence-Based Strategies to Improve Outcomes in HER2-Negative Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--